Showing posts with label News. Show all posts
Showing posts with label News. Show all posts

Saturday, 17 February 2007

COKE TAKES ON ADHD

"The STATS ADHD costs the U.S. an estimated $75 billion a year in lost productivity 8 to 12 percent of American workers have ADHD 1 in every 12 adults has ADHD"

COKE TAKES ON ADHD - By Diane Loupe

"There’s one in every office: the guy who’s smart, funny, interesting, creative and energetic—but also impulsive, chronically late and given to go on tangents in meetings. He’ll finish a report at the last minute, and it will be riddled with careless mistakes. That is, if he can find it on his messy desk to begin with. " [read more]

Source: sundaypaper.com 02/18/07

Sunday, 4 February 2007

Article: Attention Deficit Disorder--Conceptions and Misconceptions

This article by Moss David Posner M.D. (February 3, 2007) has some really thought provoking ideas about adhd, definitely worth a read:

"It seems that every day we open the newspaper or go online we see another article about Attention Deficit Disorder[i]. The subjects and titles of the articles vary from condemnation of the very notion of the existence of such an entity, to “natural” treatments for the problem, to warnings of dire consequences ranging from insanity to addiction with the use of medications, to attacks on “the drug companies” as having created the notion in the first place, to congratulations to those who are blessed with the “gift” of the disorder, and to treatments, from medications, to meditation, to physical therapies, hypnosis, and prayer ... [read more]

Sunday, 10 December 2006

End of year wrap up 2006

Well another year passes! It has been a busy year:

  • started another degree and passed the first year in spite of 'just in time' essay techniques

  • achieved my New Year resolution for 2006 - managed to tidy up my study ( and it only took 11 months to get there)

  • worked way too much and spent too little time with family and friends (looks like a New Year resolution evolving here)

  • had a good year at work, achieved targets in spite of evil & malicious co-workers and lack of funding (why do people have to bring their psychoses to work?)

  • managed to be more organised than ever before - not sure how that happened but getting an assistant at work could explain it?

  • planning my annual vacation for February - this keeps me sane for the rest of the year
Altogether another busy year. Must say having meds to call upon has really helped. I try not to take them all the time, but when things get busy I really need the help to focus.

Sunday, 12 November 2006

When Mom has ADHD

Some interesting notes about women with adhd towards the bottom of this article, click the link to read entire article:

Women with the disorder face special challenges, Columbia doctor says

By LINDA H. LAMB llamb@thestate.com

"When Peggy Ashley filled out a medical form for her hyperactive son, the doctor took one look at her messy handwriting and made a gut-level diagnosis." Read more



Press release re Free Online ADD Test

ADHD Expert Releases Free Online ADD Test
PR Web (press release) - Ferndale,WA,USA
ADHD expert Tellman Knudson is now providing special resources that provide others like himself diagnosed or affected with ADHD the real secrets, tools and ...
for more click here

Friday, 30 June 2006

Press Release: Struggles persist for adolescent girls with ADHD

The following item from a recent UC Berkely press release is very interesting. It highlights the onoing problems experienced by girls with ADHD, noting that they display more disorganised or inattentive behaviour than boys. I still think girls are being ignored in this regard.


By Yasmin Anwar, Media Relations 29 June 2006

"BERKELEY – As they enter adolescence, girls with Attention Deficit Hyperactivity Disorder (ADHD) show fewer symptoms of hyperactivity. But they continue to lag behind their peers academically and have a greater proclivity for other behavioral and emotional disorders as well as for substance abuse, according to new research from the University of California, Berkeley.

In a much-anticipated, five-year follow-up study of one of the largest samples of girls with ADHD ever examined, UC Berkeley researchers found not only that difficulties for girls suffering from the disorder persist during their teens, but that insidious new problems can emerge. These findings are published in the June issue of the Journal of Consulting and Clinical Psychology.

"As girls with ADHD mature into adolescence, on average they don't show as many visible symptoms of the condition, especially the most noticeable form - hyperactive behavior," said the study's lead author, Stephen Hinshaw, who is a UC Berkeley professor of psychology and chair of the psychology department.

"But we can't get fooled into thinking things are fine. Delinquent and depressed behaviors, risk for substance abuse, symptoms of eating disorders, high need for services, difficulties with peers - these problems hit girls with ADHD harder than they did for the comparison group without the condition," he added.

Since 1997, Hinshaw and his team have tracked a racially and socio-economically diverse group of girls with ADHD through summer camps and into adolescence, comparing them with girls who did not meet the criteria for ADHD but were otherwise demographically matched.

The childhood study, funded by a grant from the National Institute of Mental Health (NIMH), included a sample of 140 girls with ADHD and 88 without the disorder. The girls were aged six to 12. Together, they attended five-week camps where they were closely monitored as they partook in art and drama classes and outdoor activities. Those taking ADHD medication volunteered to go off the drug treatment for much of the summer camp study. The counselors and staff observing all 228 girls and monitoring their interactions did not know which of them had been diagnosed with ADHD.

Published in 2002 in the Journal of Consulting and Clinical Psychology, the initial study found that girls with ADHD are more likely to struggle academically and to be rejected by their peers, compared to the comparison peer group. Results also suggested that girls are underdiagnosed for the disorder because they are more prone to "inattentive-type" ADHD, which is marked by disorganized and unfocused behavior rather than the disruptive, impulsive conduct seen in boys.

The latest findings show that these problems clearly persist into adolescence. According to five-year follow-ups of 209 of the girls in the study, although the fidgety, impulsive symptoms exhibited during childhood had subsided in many cases, the learning gulf between girls with ADHD and their "normal" peers had remained large in all cases, and had actually widened in math and reading skills. Moreover, in many cases, risky behaviors had surfaced.

"Girls with ADHD have impairments that are not transitory but that persist through adolescence. And they are persisting in areas of function that are really crucial for success in adulthood," Hinshaw said. "They're behind academically and socially. Even if symptoms improve, underlying deficits seem chronic, and we need to do a lot more for early intervention."
For parents coping with difficult teenage ADHD behavior, Hinshaw warned, adolescence can be tricky as they try to strike a balance between encouraging their daughters to stick to their treatment regimen -which may involve medication, family therapy, school supports, or a combination - while supporting their need for autonomy.

"At the very time adolescence is occurring for these kids, demands for independence are increasing exponentially," he said.

For the follow-up study, the researchers spent two half-days with each of the girls as well as with their parents and caregivers, conducting intensive interviews and tests. The girls' classroom teachers also provided information. The objective was to learn how the girls, whose ages ranged between 12 and 17, were doing emotionally, socially and academically. The investigators also measured key cognitive functions such "executive planning skills," which include time-budgeting, adjusting to changes and goal-setting.

Hinshaw said he hopes these new findings will underscore the need for long-lasting professional intervention for children with ADHD and convince families struggling with the disorder that it's a misconception that ADHD is not a "real" condition - and that diagnosis and treatment are crucial.

His research team has won a new NIMH grant for a 10-year follow-up study of the same girls. It is set to begin later this year.

Some of the girls in the study are also participating in a UC Berkeley brain imaging project to pinpoint the source of poor executive function skills, a common component of ADHD.
As many as 7 million children in the United States have been diagnosed with this developmental and behavioral disorder, which is characterized by poor concentration, distractibility, hyperactivity, impulsiveness, aggression and other symptoms that are inappropriate for the child's age. The treatment regimens that have received the greatest research evidence are stimulant medications and various forms of behavior therapy.

Although the news is sobering, many of the girls with ADHD did show improvement across the five-year follow-up interval. A few made substantial recoveries. But on average, problems persisted and new ones emerged, which suggests that careful monitoring and treatment are essential, Hinshaw said.

In addition to Hinshaw, authors of the study are Elizabeth Owens, Nilofar Sami and Samantha Fargeon, all of UC Berkeley's psychology department and Institute of Human Development."

Source: http://www.berkeley.edu/news/media/releases/2006/06/29_adhd.shtml

Thursday, 29 June 2006

Article: Study reveals how attention deficit drugs work (Jun 26, 2006)

Study reveals how attention deficit drugs work
June 26, 2006 by Paroma Basu

"Although millions depend on medications such as Ritalin to quell symptoms of attention deficit hyperactivity disorder (ADHD), scientists have struggled to pinpoint how the drugs work in the brain.

But new work at the University of Wisconsin-Madison is now starting to clear up some of the mystery. Writing in the journal Biological Psychiatry, UW-Madison researchers report that ADHD drugs primarily target the prefrontal cortex (PFC), a region of the brain that is associated with attention, decision-making and an individual's expression of personality.

The finding could prove invaluable in the search for new ADHD treatments, and comes amidst deep public concern over the widespread abuse of existing ADHD medicines.

"There's been a lot of concern over giving a potentially addictive drug to a child (with ADHD)," says lead author Craig Berridge, a UW-Madison professor of psychology. "But in order to come up with a better drug, we must first know what the existing drugs do."

A behavioral disorder that afflicts both children and adults, ADHD is marked by hyperactivity, impulsivity and an inability to concentrate. The National Institute of Mental Health estimates that 2 million children in the U.S. suffer from the condition, with between 30 to 70 percent of them continuing to exhibit symptoms in their adult years.

Despite public anxiety over the treatment of a behavioral condition with drugs, doctors have continued to prescribe meds like Adderall, Ritalin and Dexedrine because - quite simply - they work better than anything else.

ADHD drugs fall into a class of medications known as stimulants. ADHD stimulants boost levels of two neurotransmitters, or chemical messengers in the brain, known as dopamine and norepinephrine. Dopamine is thought to play a role in memory formation and the onset of addictive behaviors, while norepinephrine has been linked with arousal and attentiveness.
Berridge notes that scientists have learned little about how ADHD drugs work because past studies have primarily examined the effects of the medicines at high doses. High-dose stimulants can cause dramatic spikes in neurotransmitter levels in the brain, which can in turn impair attention and heighten the risk of developing addiction.

"It is surprising that no one was looking at low-dose (ADHD) drugs because we know that the drugs are most effective only at low doses," says Berridge. "So we asked the natural question: what are these drugs doing at clinically relevant doses?"

To answer that question, Berridge and his team monitored neurotransmitter levels in three different brain regions thought to be targeted by ADHD drugs: the PFC and two smaller brain areas known as the accumbens which has been linked with processing "rewards," and the medial septum, which has been implicated in arousal and movement.

Working with rats, the researchers conducted laboratory and behavioral tests to ensure that animal drug doses were functionally equivalent to doses prescribed in humans. Then, using a type of brain probe - a process known as microdialysis - the UW-Madison team measured concentrations of dopamine and norepinephrine in the three different brain areas, both in the presence and absence of low-dose ADHD stimulants.

Under the influence of ADHD drugs, dopamine and norepinephrine levels increased in the rats' PFC. Levels in the accumbens and medial septum, however, remained much the same, the scientists found.

"Our work provides pretty important information on the importance of targeting the PFC when treating ADHD," says Berridge, "In particular it tells us that if we want to produce new ADHD drugs, we need to target [neurotransmitter] transmission in the PFC."

In the future, Berridge and his colleagues plan to look deeper within the PFC to gain more detailed insights into how ADHD medicines act on nerves to enhance cognitive ability.
Other contributors to the study include UW-Madison co-authors David Devilbiss, Matthew Andrzejewski, Ann Kelley, Brooke Schmeichel, Christina Hamilton and Robert Spencer, and Yale Medical School researcher Amy Arnsten. "

Source: University of Wisconsin - Madison News

Saturday, 17 June 2006

Article: More poor on ADHD drugs

A recent article in the Border Mail newspaper notes that there is a socio-economic element to prescription of drugs for adhd:

"POORER children are more likely to be prescribed drugs for attention deficit hyperactivity disorder because they can’t access alternative treatments, the Australian Medical Association says.

Medicare figures show kids in lower socio-economic areas of NSW are up to 10 times more likely to be put on ADHD drugs than those in affluent areas.

Scrips for the two major ADHD drugs available on the Pharmaceutical Benefit Scheme were issued at a rate of one for every 25 children under 14 in poor areas.

AMA vice-president and child psychiatrist Dr Choong-Siew Yong said the trend was likely to be true for Australia as a whole.

It was not surprising given that families in poorer areas generally presented with more problems than in affluent areas, Dr Yong said.

But he said it was also likely that poorer children were not accessing the non-medication treatments recommended before they’re prescribed ADHD drugs dexamphetamines and methylphenidate, marketed as Ritalin.

These alternatives include individual and family group counselling, behavioural management strategies, school support and treatment for other conditions like depression and anxiety."

Read more here ...

Source: The Border Mail, Australia, 14 June 2006